Part 10: acute coronary syndromes: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care

RE O'Connor, W Brady, SC Brooks, D Diercks, J Egan… - Circulation, 2010 - Am Heart Assoc
The 2010 AHA Guidelines for CPR and ECC for the evaluation and management of acute
coronary syndromes (ACS) are intended to define the scope of training for healthcare …

Part 9: acute coronary syndromes: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment …

RE O'Connor, L Bossaert, HR Arntz, SC Brooks… - Circulation, 2010 - Am Heart Assoc
Note From the Writing Group: Throughout this article, the reader will notice combinations of
superscripted letters and numbers (eg,“Chest Pain Observation Units ACS-005A”). These …

The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis

M Sabovic, B Salobir, I Preloznik Zupan… - … of haemostasis and …, 2006 - karger.com
In end-stage renal disease, in particularly when treated with haemodialysis, the function of
platelets, coagulation and fibrinolytic systems can be disturbed, thus contributing to either …

Prothrombotic changes in platelet, endothelial and coagulation function following hemodialysis

JA Milburn, K Cassar, I Ford, N Fluck… - … Journal of Artificial …, 2011 - journals.sagepub.com
Purpose Patients on hemodialysis (HD) have an increased risk of thrombotic events,
including myocardial infarction and vascular access thrombosis. The study hypothesis is that …

Cost-effectiveness of interventions to control cardiovascular diseases and diabetes mellitus in South Asia: a systematic review

K Singh, AM Chandrasekaran, S Bhaumik… - BMJ open, 2018 - bmjopen.bmj.com
Objectives More than 80% of cardiovascular diseases (CVD) and diabetes mellitus (DM)
burden now lies in low and middle-income countries. Hence, there is an urgent need to …

Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review

G Costantino, E Ceriani, AM Rusconi, GM Podda… - 2012 - journals.plos.org
Background Low Molecular Weight Heparins (LMWH) are at least as effective antithrombotic
drugs as Unfractionated Heparin (UFH). However, it is still unclear whether the safety …

Part 9: acute coronary syndromes: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment …

L Bossaert, RE O'Connor, HR Arntz… - …, 2010 - resuscitationjournal.com
The International Liaison Committee on Resuscitation (ILCOR) ACS-MI Task Force included
expert reviewers from Africa, Asia, Australia, Europe, North America, and South America …

The role of chemoprophylactic agents in modulating platelet aggregability after traumatic brain injury

MC Morris, F Kassam, A Bercz, N Beckmann… - Journal of surgical …, 2019 - Elsevier
Background The pathophysiology behind the subacute but persistent hypercoagulable state
after traumatic brain injury (TBI) is poorly understood but contributes to morbidity induced by …

A Randomized Controlled Clinical Trial to Evaluate the Efficacy, Safety, Cost-Effectiveness and Effect on PAI-1 Levels of the Three Low-Molecular-Weight Heparins …

N Shafiq, S Malhotra, P Pandhi, N Sharma, A Bhalla… - Pharmacology, 2006 - karger.com
Background: Comparative data for efficacy and safety between various low-molecular-
weight heparins (LMWHs) in patients with unstable angina is not available. The present …

Enoxaparin: an update of its clinical use in the management of acute coronary syndromes

T Ibbotson, KL Goa - Drugs, 2002 - Springer
Enoxaparin (enoxaparin sodium) is a low molecular weight heparin (LMWH) indicated for
use in the treatment of ischaemic complications of unstable angina and non-Q wave …